Cite Filings / KPTI / 0001104659-23-018475
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G

Amended Statement of Ownership

Karyopharm Therapeutics Inc. · Filed 2023-02-10 · Acc 0001104659-23-018475

Documents 1

  • SC 13G Amended Statement of Ownership , tm235947d15_sc13g.htm

Around this filing

  • 2024-02-13 SC 13G Amended Statement of Ownership
  • 2023-02-14 SC 13G/A Amended Statement of Ownership
  • 2023-02-14 SC 13G/A Amended Statement of Ownership
  • 2023-02-10 SC 13G Amended Statement of Ownership
  • 2023-02-08 4 EVP, CFO & Treasurer sold 4,141 shares at $3.40 ($14,079)
  • 2023-02-08 4 President and CEO sold 3,950 shares at $3.40 ($13,430)
  • 2023-01-20 SC 13G Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · RA Capital Management, L.P. 9.9%
  2. 2026-11-13 SCHEDULE 13G/A · Affinity Asset Advisors, LLC 6.5%
Loading tm235947d15_sc13g.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…